SG11201705727TA - 9h-pyrrolo-dipyridine derivatives - Google Patents

9h-pyrrolo-dipyridine derivatives

Info

Publication number
SG11201705727TA
SG11201705727TA SG11201705727TA SG11201705727TA SG11201705727TA SG 11201705727T A SG11201705727T A SG 11201705727TA SG 11201705727T A SG11201705727T A SG 11201705727TA SG 11201705727T A SG11201705727T A SG 11201705727TA SG 11201705727T A SG11201705727T A SG 11201705727TA
Authority
SG
Singapore
Prior art keywords
pyrrolo
9h
dipyridine
derivatives
dipyridine derivatives
Prior art date
Application number
SG11201705727TA
Inventor
Joël Mercier
Laurent Provins
Celine Vermeiren
Yogesh Anil Sabnis
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP15153448 priority Critical
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Priority to PCT/EP2016/051993 priority patent/WO2016124508A1/en
Publication of SG11201705727TA publication Critical patent/SG11201705727TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0463Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
SG11201705727TA 2015-02-02 2016-01-29 9h-pyrrolo-dipyridine derivatives SG11201705727TA (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP15153448 2015-02-02
PCT/EP2016/051993 WO2016124508A1 (en) 2015-02-02 2016-01-29 9h-pyrrolo-dipyridine derivatives

Publications (1)

Publication Number Publication Date
SG11201705727TA true SG11201705727TA (en) 2017-08-30

Family

ID=52477553

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201705727TA SG11201705727TA (en) 2015-02-02 2016-01-29 9h-pyrrolo-dipyridine derivatives

Country Status (13)

Country Link
US (1) US20180022748A1 (en)
EP (1) EP3253762A1 (en)
KR (1) KR20170113607A (en)
CN (1) CN107207508A (en)
AU (1) AU2016214537B2 (en)
BR (1) BR112017016311A2 (en)
CA (1) CA2973648A1 (en)
CL (1) CL2017001923A1 (en)
EA (1) EA201791733A1 (en)
IL (1) IL253381D0 (en)
MX (1) MX2017009505A (en)
SG (1) SG11201705727TA (en)
WO (1) WO2016124508A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018015549A1 (en) 2016-07-22 2018-01-25 Ac Immune S.A. Compounds for imaging tau protein aggregates
JP2019524881A (en) 2016-07-22 2019-09-05 エーシー・イミューン・エス・アー Compounds for imaging tau protein aggregates
WO2019145291A1 (en) 2018-01-24 2019-08-01 Ac Immune Sa Gamma-carboline compounds for the detection of tau aggregates
WO2019145292A1 (en) * 2018-01-24 2019-08-01 Ac Immune Sa Azacarboline compounds for the detection of tau aggregates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008132454A1 (en) * 2007-04-26 2008-11-06 Ge Healthcare Limited Carbolines and their use as imaging agents
JP5976206B2 (en) * 2012-05-22 2016-08-23 イーライ リリー アンド カンパニー Contrast agent for detecting neurological dysfunction
EP2247558A1 (en) * 2008-02-14 2010-11-10 Siemens Medical Solutions USA, Inc. Novel imaging agents for detecting neurological dysfunction
EP3055308B1 (en) * 2013-10-08 2017-11-22 F.Hoffmann-La Roche Ag Diazacarbazole derivatives as tau-pet-ligands

Also Published As

Publication number Publication date
BR112017016311A2 (en) 2018-03-27
EA201791733A1 (en) 2018-01-31
CA2973648A1 (en) 2016-08-11
EP3253762A1 (en) 2017-12-13
MX2017009505A (en) 2017-11-02
KR20170113607A (en) 2017-10-12
IL253381D0 (en) 2017-09-28
CN107207508A (en) 2017-09-26
AU2016214537B2 (en) 2018-05-10
WO2016124508A1 (en) 2016-08-11
JP2018503673A (en) 2018-02-08
CL2017001923A1 (en) 2018-02-16
AU2016214537A1 (en) 2017-08-03
US20180022748A1 (en) 2018-01-25

Similar Documents

Publication Publication Date Title
IL254030D0 (en) שימוש בפרידופידין לשיפור תפקוד קוגניטיבי ולטיפול במחלת אלצהיימר
GB201514938D0 (en) Braring calculation
IL255194D0 (en) Solid forms
GB201514754D0 (en) Compounds
GB201514751D0 (en) Compounds
IL252777D0 (en) Dihydroindolizinone derivative
GB201707959D0 (en) No details
GB201612542D0 (en) no details
IL253381D0 (en) 9h-pyrrolo-dipyridine derivatives
LT3097076T (en) Novel cyp-eicosanoid derivatives
IL248773D0 (en) Naphthyridinedione derivatives
AU201616677S (en) Cylindres
GB201522311D0 (en) Use
IL253813D0 (en) Diaza-benzofluoranthrene compounds
GB201520500D0 (en) Compounds
GB201520499D0 (en) Compounds
GB201518762D0 (en) Methods
IL248772D0 (en) Cyclohexyl-pyridine derivative
GB201706130D0 (en) No details
GB201513390D0 (en) Aortopathy
GB201509585D0 (en) -
SE1550032A1 (en) Gravitationsmotor
GB201506824D0 (en) TrailReach Multitrial
PL3119744T3 (en) 2-cyano-3-cyclopropyl-3-hydroxy-n-aryl-thioacrylamide derivatives
SG11201608634RA (en) Cycloalkyl-linked diheterocycle derivatives